1. Home
  2. RAPP vs CBLL Comparison

RAPP vs CBLL Comparison

Compare RAPP & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPP
  • CBLL
  • Stock Information
  • Founded
  • RAPP 2022
  • CBLL 2014
  • Country
  • RAPP United States
  • CBLL United States
  • Employees
  • RAPP N/A
  • CBLL N/A
  • Industry
  • RAPP
  • CBLL
  • Sector
  • RAPP
  • CBLL
  • Exchange
  • RAPP Nasdaq
  • CBLL Nasdaq
  • Market Cap
  • RAPP 439.4M
  • CBLL 433.7M
  • IPO Year
  • RAPP 2024
  • CBLL 2024
  • Fundamental
  • Price
  • RAPP $30.52
  • CBLL $12.07
  • Analyst Decision
  • RAPP Strong Buy
  • CBLL Strong Buy
  • Analyst Count
  • RAPP 3
  • CBLL 6
  • Target Price
  • RAPP $34.67
  • CBLL $33.00
  • AVG Volume (30 Days)
  • RAPP 904.6K
  • CBLL 289.4K
  • Earning Date
  • RAPP 11-06-2025
  • CBLL 08-05-2025
  • Dividend Yield
  • RAPP N/A
  • CBLL N/A
  • EPS Growth
  • RAPP N/A
  • CBLL N/A
  • EPS
  • RAPP N/A
  • CBLL N/A
  • Revenue
  • RAPP N/A
  • CBLL $77,419,000.00
  • Revenue This Year
  • RAPP N/A
  • CBLL $35.06
  • Revenue Next Year
  • RAPP N/A
  • CBLL $28.56
  • P/E Ratio
  • RAPP N/A
  • CBLL N/A
  • Revenue Growth
  • RAPP N/A
  • CBLL 42.16
  • 52 Week Low
  • RAPP $6.43
  • CBLL $10.01
  • 52 Week High
  • RAPP $42.14
  • CBLL $32.75
  • Technical
  • Relative Strength Index (RSI)
  • RAPP 77.94
  • CBLL 44.45
  • Support Level
  • RAPP $14.11
  • CBLL $11.18
  • Resistance Level
  • RAPP $42.27
  • CBLL $12.60
  • Average True Range (ATR)
  • RAPP 2.64
  • CBLL 0.48
  • MACD
  • RAPP 1.47
  • CBLL 0.21
  • Stochastic Oscillator
  • RAPP 58.57
  • CBLL 62.81

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

About CBLL CeriBell Inc. Common Stock

CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.

Share on Social Networks: